Minneapolis, United States
Bio-Techne, a Minneapolis-based company, excels as a prominent global force in the biotechnology industry. Since its inception in 1981—as R&D Systems—and subsequent rebranding in 2014, Bio-Techne has demonstrated significant growth and diversification.
The company operates on a large scale, employing over 3,000 individuals worldwide and maintaining a strategic presence across 34 locations. Bio-Techne boasts an impressive product portfolio, featuring over 500,000 types of reagents, analytical instruments, and precision diagnostics.
Financially, the company is robust, reporting net sales exceeding $1.1 billion in the fiscal year 2023. This strong financial performance is buoyed by a strategic mix of acquisitions, organic investments, and market diversifications.
Bio-Techne's portfolio includes renowned brands such as ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems, and Tocris Bioscience, anchoring its leadership in biotechnology solutions and diagnostics.
-logo.jpg "Lunaphore (a Bio-Techne brand)"){kind=logo}
